{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:37:09Z","timestamp":1794440229046,"version":"4.9.1"},"reference-count":94,"publisher":"BMJ","issue":"14","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Sports Med"],"accepted":{"date-parts":[[2018,10,29]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the effect of exercise regimens and medications on systolic blood pressure (SBP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Medline (via PubMed) and the Cochrane Library.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Randomised controlled trials (RCTs) of angiotensin-converting enzyme inhibitors (ACE-I), angiotensin-2 receptor blockers (ARBs), \u03b2-blockers, calcium channel blockers (CCBs) and diuretics were identified from existing Cochrane reviews. A previously published meta-analysis of exercise interventions was updated to identify recent RCTs that tested the SBP-lowering effects of endurance, dynamic resistance, isometric resistance, and combined endurance and resistance exercise interventions (up to September 2018).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Random-effects network meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome<\/jats:title>\n                    <jats:p>Difference in mean change from baseline SBP between comparator treatments (change from baseline in one group minus that in the other group) and its 95% credible interval (95% CrI), measured in mmHg.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included a total of 391 RCTs, 197 of which evaluated exercise interventions (10\u2009461 participants) and 194 evaluated antihypertensive medications (29\u2009281 participants). No RCTs compared directly exercise against medications. While all medication trials included hypertensive populations, only 56 exercise trials included hypertensive participants (\u2265140\u2009mmHg), corresponding to 3508 individuals. In a 10% random sample, risk of bias was higher in exercise RCTs, primarily due to lack of blinding and incomplete outcome data. In analyses that combined all populations, antihypertensive medications achieved higher reductions in baseline SBP compared with exercise interventions (mean difference \u22123.96\u2009mmHg, 95% CrI \u22125.02 to \u22122.91). Compared with control, all types of exercise (including combination of endurance and resistance) and all classes of antihypertensive medications were effective in lowering baseline SBP. Among hypertensive populations, there were no detectable differences in the SBP-lowering effects of ACE-I, ARB, \u03b2-blocker and diuretic medications when compared with endurance or dynamic resistance exercise. There was no detectable inconsistency between direct and indirect comparisons. Although there was evidence of small-study effects, this affected both medication and exercise trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The effect of exercise interventions on SBP remains under-studied, especially among hypertensive populations. Our findings confirm modest but consistent reductions in SBP in many studied exercise interventions across all populations but individuals receiving medications generally achieved greater reductions than those following structured exercise regimens. Assuming equally reliable estimates, the SBP-lowering effect of exercise among hypertensive populations appears similar to that of commonly used antihypertensive medications. Generalisability of these findings to real-world clinical settings should be further evaluated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjsports-2018-099921","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T23:55:18Z","timestamp":1545177318000},"page":"859-869","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":295,"title":["How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure"],"prefix":"10.1136","volume":"53","author":[{"given":"Huseyin","family":"Naci","sequence":"first","affiliation":[{"name":"Department of Health Policy, London School of Economics and Political Science, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Salcher-Konrad","sequence":"additional","affiliation":[{"name":"Department of Health Policy, London School of Economics and Political Science, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-0221","authenticated-orcid":false,"given":"Sofia","family":"Dias","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"Centre for Reviews and Dissemination, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel R","family":"Blum","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"},{"name":"Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA"},{"name":"Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samali Anova","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Management, The Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nunan","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P A","family":"Ioannidis","sequence":"additional","affiliation":[{"name":"Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA"},{"name":"Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA"},{"name":"Stanford Prevention Center, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"2025080115203723000_53.14.859.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"2025080115203723000_53.14.859.2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410050036006"},{"key":"2025080115203723000_53.14.859.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.77.3.504"},{"key":"2025080115203723000_53.14.859.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.5.801"},{"key":"2025080115203723000_53.14.859.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61766-8"},{"key":"2025080115203723000_53.14.859.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)00016-2"},{"key":"2025080115203723000_53.14.859.7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamacardio.2016.0218","article-title":"Drugs for primary prevention of atherosclerotic cardiovascular disease: an overview of systematic reviews","volume":"1","author":"Karmali","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2025080115203723000_53.14.859.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61212-5"},{"key":"2025080115203723000_53.14.859.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.004046"},{"key":"2025080115203723000_53.14.859.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.096156"},{"key":"2025080115203723000_53.14.859.11","unstructured":"NHS Digital. Prescriptions Dispensed in the Community England 2006 to 2016. 2017 https:\/\/files.digital.nhs.uk\/publication\/s\/o\/pres-disp-com-eng-2006-16-rep.pdf."},{"key":"2025080115203723000_53.14.859.12","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"2025080115203723000_53.14.859.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2357"},{"key":"2025080115203723000_53.14.859.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032582"},{"key":"2025080115203723000_53.14.859.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.13766"},{"key":"2025080115203723000_53.14.859.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2007.12.002"},{"key":"2025080115203723000_53.14.859.17","unstructured":"OECD. Health at a Glance. 2017 https:\/\/www.oecd-ilibrary.org\/social-issues-migration-health\/health-at-a-glance_19991312."},{"key":"2025080115203723000_53.14.859.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11237"},{"key":"2025080115203723000_53.14.859.19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/oxfordjournals.aje.a115704","article-title":"A meta-analysis of physical activity in the prevention of coronary heart disease","volume":"132","author":"Berlin","year":"1990","journal-title":"Am J Epidemiol"},{"key":"2025080115203723000_53.14.859.20","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.051351"},{"key":"2025080115203723000_53.14.859.21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph9020391"},{"key":"2025080115203723000_53.14.859.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2014.12.041"},{"key":"2025080115203723000_53.14.859.23","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1881"},{"key":"2025080115203723000_53.14.859.24","doi-asserted-by":"publisher","DOI":"10.1097\/00008483-200605000-00002"},{"key":"2025080115203723000_53.14.859.25","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.10.999"},{"key":"2025080115203723000_53.14.859.26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-7-200204020-00006"},{"key":"2025080115203723000_53.14.859.27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.004473"},{"key":"2025080115203723000_53.14.859.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5577"},{"key":"2025080115203723000_53.14.859.29","unstructured":"National Institute for Health and Care Excellence. CG 127: Hypertension in adults: diagnosis and management. 2016 https:\/\/www.nice.org.uk\/guidance\/cg127."},{"key":"2025080115203723000_53.14.859.30","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328364ca4c"},{"key":"2025080115203723000_53.14.859.31","first-page":"41","article-title":"The British National Formulary: checking, medicines and clinicians","volume":"215","author":"Dickson","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"2025080115203723000_53.14.859.32","unstructured":"Higgins J , Green S . Cochrane handbook for systematic reviews of interventions Version 5.1. 0: The Cochrane Collaboration, 2011."},{"key":"2025080115203723000_53.14.859.33","first-page":"126","article-title":"Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research","volume":"100","author":"Caspersen","year":"1985","journal-title":"Public Health Rep"},{"key":"2025080115203723000_53.14.859.34","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-199806000-00032"},{"key":"2025080115203723000_53.14.859.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"2025080115203723000_53.14.859.36","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-7-200804010-00011"},{"key":"2025080115203723000_53.14.859.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"2025080115203723000_53.14.859.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7521.897"},{"key":"2025080115203723000_53.14.859.39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2914"},{"key":"2025080115203723000_53.14.859.40","doi-asserted-by":"publisher","DOI":"10.1177\/0962280207080643"},{"key":"2025080115203723000_53.14.859.41","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1875"},{"key":"2025080115203723000_53.14.859.42","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-2-201307160-00008"},{"key":"2025080115203723000_53.14.859.43","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008929526011"},{"key":"2025080115203723000_53.14.859.44","unstructured":"Dias S , Welton NJ , Sutton AJ , et al . NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. London: National Institute for Health and Care Excellence (NICE), 2011."},{"key":"2025080115203723000_53.14.859.45","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12458724"},{"key":"2025080115203723000_53.14.859.46","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X13487604"},{"key":"2025080115203723000_53.14.859.47","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.12"},{"key":"2025080115203723000_53.14.859.48","unstructured":"Dias S , Welton NJ , Sutton AJ , et al . Inconsistency in networks of evidence based on randomised controlled trials. London: NICE Decision Support Unit, 2011. NICE DSU Technical Support Document 4."},{"key":"2025080115203723000_53.14.859.49","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12455847"},{"key":"2025080115203723000_53.14.859.50","doi-asserted-by":"publisher","DOI":"10.1198\/016214505000001302"},{"key":"2025080115203723000_53.14.859.51","unstructured":"Dias S , Sutton AJ , Welton NJ , et al . Heterogeneity: subgroups, meta-regression, bias and bias-adjustment. London: National Institute for Health and Care Excellence (NICE), 2011."},{"key":"2025080115203723000_53.14.859.52","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X13485157"},{"key":"2025080115203723000_53.14.859.53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2981"},{"key":"2025080115203723000_53.14.859.54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-9-2"},{"key":"2025080115203723000_53.14.859.55","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1467-985X.2010.00639.x","article-title":"Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta-analysis","volume":"173","author":"Dias","year":"2010","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"2025080115203723000_53.14.859.56","doi-asserted-by":"crossref","unstructured":"Heran BS , Wong MM , Heran IK , et al . Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev 2008:CD003822.doi:10.1002\/14651858.CD003822.pub2","DOI":"10.1002\/14651858.CD003822.pub2"},{"key":"2025080115203723000_53.14.859.57","doi-asserted-by":"crossref","unstructured":"Heran BS , Wong MM , Heran IK , et al . Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. Cochrane Database Syst Rev 2008:CD003823.doi:10.1002\/14651858.CD003823.pub2","DOI":"10.1002\/14651858.CD003823.pub2"},{"key":"2025080115203723000_53.14.859.58","first-page":"CD010052","article-title":"Time course for blood pressure lowering of dihydropyridine calcium channel blockers","volume":"8","author":"Ghamami","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025080115203723000_53.14.859.59","doi-asserted-by":"crossref","unstructured":"Musini VM , Nazer M , Bassett K , et al . Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev 2014:CD003824.doi:10.1002\/14651858.CD003824.pub2","DOI":"10.1002\/14651858.CD003824.pub2"},{"key":"2025080115203723000_53.14.859.60","doi-asserted-by":"crossref","unstructured":"Wong GW , Boyda HN , Wright JM . Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension. Cochrane Database Syst Rev 2014:CD007450.doi:10.1002\/14651858.CD007450.pub2","DOI":"10.1002\/14651858.CD007450.pub2"},{"key":"2025080115203723000_53.14.859.61","first-page":"CD007451","article-title":"Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension","volume":"3","author":"Wong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025080115203723000_53.14.859.62","doi-asserted-by":"crossref","unstructured":"Wong GW , Wright JM . Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension. Cochrane Database Syst Rev 2014:CD007452.doi:10.1002\/14651858.CD007452.pub2","DOI":"10.1002\/14651858.CD007452.pub2"},{"key":"2025080115203723000_53.14.859.63","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials","volume":"356","author":"Blood Pressure Lowering Treatment Trialists\u2019Collaboration","year":"2000","journal-title":"The Lancet"},{"key":"2025080115203723000_53.14.859.64","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14739-3"},{"key":"2025080115203723000_53.14.859.65","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39548.738368.BE"},{"key":"2025080115203723000_53.14.859.66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01225-8"},{"key":"2025080115203723000_53.14.859.67","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200502000-00003"},{"key":"2025080115203723000_53.14.859.68","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000184225.05629.51"},{"key":"2025080115203723000_53.14.859.69","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2014-094157"},{"key":"2025080115203723000_53.14.859.70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/hr.2015.111","article-title":"Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit","volume":"39","author":"Inder","year":"2016","journal-title":"Hypertens Res"},{"key":"2025080115203723000_53.14.859.71","doi-asserted-by":"publisher","DOI":"10.1177\/2047487316664147"},{"key":"2025080115203723000_53.14.859.72","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-015-1412-3","article-title":"National physical activity recommendations: systematic overview and analysis of the situation in European countries","volume":"15","author":"Kahlmeier","year":"2015","journal-title":"BMC Public Health"},{"key":"2025080115203723000_53.14.859.73","unstructured":"NHS Choices. Physical activity guidelines for adults. https:\/\/www.nhs.uk\/live-well\/exercise\/."},{"key":"2025080115203723000_53.14.859.74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0838.2006.00520.x"},{"key":"2025080115203723000_53.14.859.75","doi-asserted-by":"publisher","DOI":"10.1111\/sms.12415"},{"key":"2025080115203723000_53.14.859.76","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2010.194381"},{"key":"2025080115203723000_53.14.859.77","doi-asserted-by":"publisher","DOI":"10.3399\/096016407782604866"},{"key":"2025080115203723000_53.14.859.78","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6462"},{"key":"2025080115203723000_53.14.859.79","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1389"},{"key":"2025080115203723000_53.14.859.80","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60898-8"},{"key":"2025080115203723000_53.14.859.81","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60646-1"},{"key":"2025080115203723000_53.14.859.82","unstructured":"European Commission. Special Eurobarometer 412 - sport and physical activity. 2014 http:\/\/ec.europa.eu\/commfrontoffice\/publicopinion\/archives\/ebs\/ebs_412_en.pdf."},{"key":"2025080115203723000_53.14.859.83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jama.2017.19672","article-title":"Diagnosis and treatment of hypertension in the 2017 ACC\/AHA guidelines and in the real world","volume":"319","author":"Ioannidis","year":"2018","journal-title":"JAMA"},{"key":"2025080115203723000_53.14.859.84","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/a-0649-1040","article-title":"Do exercise trials for hypertension adequately report interventions? A reporting quality study","volume":"39","author":"Hacke","year":"2018","journal-title":"Int J Sports Med"},{"key":"2025080115203723000_53.14.859.85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2009.02240.x"},{"key":"2025080115203723000_53.14.859.86","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-097621"},{"key":"2025080115203723000_53.14.859.87","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0764-6"},{"key":"2025080115203723000_53.14.859.88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086754","article-title":"Characteristics of networks of interventions: a description of a database of 186 published networks","volume":"9","author":"Nikolakopoulou","year":"2014","journal-title":"PLoS One"},{"key":"2025080115203723000_53.14.859.89","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-018-2740-2","article-title":"Planning a future randomized clinical trial based on a network of relevant past trials","volume":"19","author":"Salanti","year":"2018","journal-title":"Trials"},{"key":"2025080115203723000_53.14.859.90","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-159"},{"key":"2025080115203723000_53.14.859.91","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.11228"},{"key":"2025080115203723000_53.14.859.92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/PHM.0000000000000521","article-title":"Blinding in physical therapy trials and its association with treatment effects: a meta-epidemiological study","volume":"96","author":"Armijo-Olivo","year":"2017","journal-title":"Am J Phys Med Rehabil"},{"key":"2025080115203723000_53.14.859.93","doi-asserted-by":"crossref","first-page":"e2005761","DOI":"10.1371\/journal.pbio.2005761","article-title":"Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality","volume":"16","author":"Rezende","year":"2018","journal-title":"PLoS Biol"},{"key":"2025080115203723000_53.14.859.94","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002"}],"container-title":["British Journal of Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjsports-2018-099921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T22:20:46Z","timestamp":1754086846000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjsm.bmj.com\/lookup\/doi\/10.1136\/bjsports-2018-099921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":94,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2019,6,27]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/bjsports-2018-099921"],"URL":"https:\/\/doi.org\/10.1136\/bjsports-2018-099921","relation":{},"ISSN":["0306-3674","1473-0480"],"issn-type":[{"value":"0306-3674","type":"print"},{"value":"1473-0480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,18]]}}}